Evidence map›Paper›PMID 40868646›Full record

ReviewHealthcare (Basel, Switzerland)2025

A Global Perspective of Color Vision Deficiency: Awareness, Diagnosis, and Lived Experiences.

Ali Almustanyir

Abstract readReview
In one paragraph

Review in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ali AlmustanyirOptometry Department, College of Applied Medical Sciences, King Saud University, Riyadh 11362, Saudi Arabia.ORCID 0000-0002-3225-3075

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Color vision deficiency (CVD), commonly referred to as color blindness, affects a significant portion of the global population, particularly among males. This narrative review synthesizes findings from peer-reviewed articles and published large-scale epidemiological studies identified through database searches using terms such as "color vision deficiency," "color blindness," "awareness," and "diagnosis." Studies were included if they addressed prevalence, awareness, diagnosis, or lived experiences of individuals with CVD. The prevalence of CVD varies by population, with red-green CVD affecting up to 8% of males and 0.5% of females of Northern European descent and lower rates reported in Asian and African populations. Although CVD is congenital in most cases, diagnosis is often delayed until school age or later due to limited routine screening, with many individuals remaining unaware of their condition until adolescence or adulthood. This delay can result in significant educational, occupational, and psychosocial challenges. This review synthesizes the current literature on the prevalence of CVD, levels of awareness, the age and process of diagnosis, and the lived experiences of individuals affected by this condition. Recommendations are provided for early detection, educational adaptations, and societal support.

Indexed as

awarenesscolor vision deficiencycolor vision diagnosisred–green vision

Identifiers

PMID40868646
PMCPMC12385717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.